Dr. Abhimanyu Mahajan is a board-certified neurologist with fellowship training in movement disorders including botulinum toxin injections and DBS programming. His primary research interests lie in the pathophysiology and clinical manifestations of dystonia. Broader areas of interest lie in aging and the use of epidemiology and imaging to explore non-motor features in disorders of motor function. He is also interested in factors affecting graduate medical education. Currently, he serves on the American Academy of Neurology (AAN) Graduate Education Subcommittee and the International Parkinson’s disease and Movement disorders Society (MDS) Dystonia Study Group. Dr. Mahajan has received funding from the Dystonia Medical Research Foundation (DMRF), Sunflower Parkinson’s disease Foundation and the Parkinson’s Foundation. After medical school, Dr. Mahajan obtained a Masters in Epidemiology with a concentration in aging at the Johns Hopkins Bloomberg School of Public Health and a certificate in gerontology from the Johns Hopkins Center of Aging and Health in Baltimore, MD. During this time, he also worked as a graduate research assistant in the Movement disorders division at the Johns Hopkins School of Medicine. He completed his Neurology residency at Henry Ford Hospital in Detroit and Movement disorders fellowship at the University of Cincinnati where he was the 2019 DMRF clinical fellow. For his work on cervical dystonia and substance abuse using the Dystonia coalition database, he received the 2018 AAN Young Investigators award. He received the 2018 junior investigator award from the Parkinson Study Group (PSG) for work using magnetoencephalography (MEG) in cervical dystonia. His effort on exploring the clinical relationship between cancer and Parkinson’s disease, biological opposites, led to the 2020 AAN Alliance Award: Founders.
- Rush University Medical Center
- Chicago, IL